Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bedminster, New Jersey
- Most recent report
- 8-K, filed Nov 3, 2026
- Incorporated
- Delaware
- Filings on record
- 576 filings
- On EDGAR
- CIK 1582554
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 54
News 8 of 140
- 8-K Other events Nov 3, 2026
- 8-K Current report on a material event Sep 28, 2026
- 8-K Other events Sep 16, 2026
- 8-K Other events Sep 4, 2026
- 8-K Current report on a material event Jul 24, 2026
- 8-K Leadership change Jul 13, 2026
- 8-K Other events Jun 26, 2026
- 8-K Current report on a material event Apr 3, 2026
Prospectuses and Registrations 8 of 44
- S-3 Shelf registration statement Jun 16, 2026
- S-8 Registration statement for an employee plan Jun 23, 2025
- 424B3 Prospectus supplement for an offering Apr 29, 2025
- S-3 Shelf registration statement Apr 22, 2025
- 424B5 Prospectus supplement for an offering Apr 4, 2024
- 424B5 Prospectus supplement for an offering Jul 7, 2023
- S-3 Shelf registration statement Jun 9, 2023
- S-8 Registration statement for an employee plan Mar 31, 2023
Proxies 8 of 19
- DEF 14A Proxy statement for a shareholder vote May 12, 2025
- PRE 14A Preliminary proxy statement May 2, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 3, 2025
- PRE 14A Preliminary proxy statement Feb 21, 2025
- DEF 14A Proxy statement for a shareholder vote Sep 19, 2023
- PRE 14A Preliminary proxy statement Sep 8, 2023
- DEF 14A Proxy statement for a shareholder vote Sep 22, 2022
- DEF 14A Proxy statement for a shareholder vote Sep 17, 2021
Ownership 8 of 256
- 4/A Insider reported a trade, amended Nov 9, 2026
- 4/A Insider reported a trade, amended Nov 9, 2026
- 4/A Insider reported a trade, amended Nov 9, 2026
- 4 Insider reported a trade Nov 6, 2026
- 4 Insider reported a trade Nov 6, 2026
- 4 Insider reported a trade Nov 6, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Aug 13, 2026
- 4 Insider reported a trade Aug 13, 2026
Other 8 of 63
Everything here comes from Matinas BioPharma Holdings, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.